Kozak v. Medtronic, Inc.

512 F. Supp. 2d 913, 2007 U.S. Dist. LEXIS 17701, 2007 WL 788163
CourtDistrict Court, S.D. Texas
DecidedMarch 14, 2007
DocketCivil Action H-03-4400
StatusPublished
Cited by4 cases

This text of 512 F. Supp. 2d 913 (Kozak v. Medtronic, Inc.) is published on Counsel Stack Legal Research, covering District Court, S.D. Texas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Kozak v. Medtronic, Inc., 512 F. Supp. 2d 913, 2007 U.S. Dist. LEXIS 17701, 2007 WL 788163 (S.D. Tex. 2007).

Opinion

ORDER DENYING RECONSIDERATION

EWING WERLEIN, JR., District Judge.

Pending is Plaintiffs Motion to Clarify or Reconsider Daubert Rulings (Document No. 126), requesting reconsideration of a portion of the Order entered September 28, 2006 (Document No. 123) to clarify that David Leathers and Jeffrey Kozak may offer expert testimony on future damages as to Plaintiffs misappropriation of trade secrets claim. 1 Defendant has filed its response in opposition.

I. Leathers

Defendant Medtronic- Sofamor Da-nek, Inc. does not deny that future damages are allowable under Tennessee law for misappropriation of a trade secret, but objects that Leathers did not form or disclose an expert opinion or report for future damages based on misappropriation of trade secrets. Fed.R.Civ.P. 26(a)(2)(B) provides that an expert report “shall contain a complete statement of all opinions to be expressed and the basis and reasons therefor; the data or other information considered by the witness in forming the opinions; [and] any exhibits to be used as a summary of or support for the opinions ...” Fed. R. Civ. P. 26(a)(2)(B) (emphasis added). “Advisory Committee Notes to the 1993 Amendment to that Rule state that the quoted requirement is intended to reduce, or possibly even to eliminate, the need to depose experts — a plain indication that the report should stand on its own.” Nilssen v. Motorola, Inc., No. 93 C 6333, 1998 WL 851493, at *2 (N.D.Ill.Dec.1, 1998). A party that fails, without substantial justification, to disclose information required by Rule 26(a) is not permitted to use the undisclosed material as evidence at trial unless it proves that its failure to disclose was harmless or substantially justified. See Fed. R. Civ. P. 37(c)(1).

The Court has carefully considered David Leathers’s Expert Report and his Supplemental Expert Report. The premise for both is set forth in the “Background” section of his report dated February 2, 2005 (which is supplemented by his February 22, 2005 report), detailing the *916 Purchase Agreement with its royalty provisions, and proceeding to state, “I understand that Medtronic chose to ignore its contractual obligation to Dr. Kozak and began marketing an anterior lumbar plate, known as the Pyramid Anterior Plate Fixation System (‘Pyramid’).” Everything that follows about damages in both of Leathers’s reports is premised on the breach of contract claim. In neither report does Leathers state any “understanding” that Medtronic misappropriated from Dr. Kozak a trade secret, what that trade secret was, whether the trade secret was contained in the Pyramid Plate, or how one with Leathers’s skill and experience would go about appraising the value of a trade secret. Instead, relying on the breach of contract premise, Leathers applies the Purchase Agreement’s contracted royalty rate (for the sale of Plaintiffs anterior lumbar plating system) to projected future sales of Defendant’s Pyramid Plate and to future generations of an anterior lumbar plate. 2

Nowhere in his Reports does Leathers perform a damages analysis for misappropriation of trade secrets, nor does he opine on matters such as (1) the actual loss to Plaintiff caused by the use of his trade secret(s), (2) Defendant’s unjust enrichment or profits from such use, or (3) a “reasonable royalty” for the use of Plaintiffs trade secret(s). See Tenn.Code Ann. § 47-25-1704(a) (describing measure of damages available for misappropriation of trade secrets claim under Tennessee’s Uniform Trade Secrets Act). Indeed, during his deposition, Leathers could not identify a specific feature in the Pyramid Plate that came from Plaintiffs design. See Doeument No. 129 ex. 2 at 121-22 (testifying that “I can’t put my finger on a specific design to make that link between [Plaintiffs] concept to this specific design to the actual Pyramid Plate.”). In short, Leathers has not disclosed or provided a future damages analysis based on misappropriation of trade secrets. See Fed. R. Civ. P. 26(a)(2)(B) (expert’s report “shall contain a complete statement of all opinions to be expressed and the basis and reasons therefor”).

Plaintiff argues that testimony from Defendant’s witnesses will show that the Purchase Agreement’s contracted royalty rate is a reasonable benchmark for the calculation of misappropriation damages, and that “trade secret damages harmonize with contract damages.” This is merely a “post-hoc rationalization” of Leathers’s expert opinions on damages for breach of contract. Leathers himself in his Reports never opined that any royalty under the Purchase Agreement or otherwise was a “reasonable” measure of damages for the misappropriation of a trade secret. See Nilssen, 1998 WL 851493, at *2 (plaintiff could not “save [an expert’s] report” by submitting a “post-hoc rationalization” that an expert considered certain factors in arriving at a reasonable royalty for a misappropriation of trade secrets claim because the expert himself did not refer to those factors “either explicitly or implicitly” in his report; thus, plaintiffs “after-the-fact manufacture of additional support for [the expert’s] opinion” failed, and the testimony would be excluded); see also Fed. R. Crv. P. 26(a)(2)(B). In sum, because Leathers did not disclose or render an expert opin *917 ion as to future damages for the misappropriation of any identifiable trade seeret(s) pursuant to Rule 26(a)(2)(B), the Court will not reconsider its , order excluding Leathers’s testimony on future damages. 3

II. Dr. Kozak

Plaintiff also asks the Court to reconsider its order by allowing him to give expert testimony on future damages for misappropriation of trade secrets. The principal question here is whether Dr. Kozak is actually an expert at formulating damage models such as the one he wants to present.

The admissibility of expert testimony is governed by Fed.R.Evid. 702, which states:

If scientific, technical, or other specialized knowledge will assist the trier of fact to understand the evidence or to determine a fact in issue, a witness qualified as an expert by knowledge, skill, experience, training or education, may testify thereto in the form of an opinion or otherwise, if (1) the testimony is based upon sufficient facts or data, (2) the testimony is the product of reliable principles and methods, and (3) the witness has applied the principles and methods reliably to the facts of the case.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
512 F. Supp. 2d 913, 2007 U.S. Dist. LEXIS 17701, 2007 WL 788163, Counsel Stack Legal Research, https://law.counselstack.com/opinion/kozak-v-medtronic-inc-txsd-2007.